Macrolides: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "==Source==" to "==References== <references/>") |
Neil.m.young (talk | contribs) (Text replacement - "* " to "*") |
||
| Line 1: | Line 1: | ||
* Erythromycin, Clarithromycin, Azithromycin | *Erythromycin, Clarithromycin, Azithromycin | ||
** Community-acquired PNA | **Community-acquired PNA | ||
** Mycoplasma | **Mycoplasma | ||
** Legionnaires' Disease | **Legionnaires' Disease | ||
** Chlamydia (single dose) | **Chlamydia (single dose) | ||
** H. Pylori | **H. Pylori | ||
** Traveler's diarrhea (children and pregnant women) | **Traveler's diarrhea (children and pregnant women) | ||
{{Template:Clinically Utilized Antibiotics}} | {{Template:Clinically Utilized Antibiotics}} | ||
Revision as of 15:42, 4 July 2016
- Erythromycin, Clarithromycin, Azithromycin
- Community-acquired PNA
- Mycoplasma
- Legionnaires' Disease
- Chlamydia (single dose)
- H. Pylori
- Traveler's diarrhea (children and pregnant women)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
See Also
References
Goodman & Gilman's Pharmacology